AstraZeneca ups investment in messenger RNA drugs with Ethris deal Ruby Khatun Khatun23 Aug 2017 9:30 AM ISTFRANKFURT: AstraZeneca has stepped up its investment in messenger RNA drugs, a promising approach in genetic therapy, by spending more than 25 million...
Johnson and Johnson ordered to pay 417 million dollar in trial over talc cancer risks Ruby Khatun Khatun22 Aug 2017 1:28 PM ISTA California jury on Monday ordered Johnson and Johnson to pay $417 million to a woman who claimed she developed ovarian cancer after using the...
ICMR partners with IVI, invests Rs 3.20 crore for vaccine development in India Ruby Khatun Khatun22 Aug 2017 11:30 AM ISTNew Delhi: The Indian Council of Medical Research (ICMR) and the Union Ministry of Health inked a pact with the International Vaccine Institute (IVI),...
Suven Life secures product patent in Japan Ruby Khatun Khatun22 Aug 2017 10:30 AM ISTNew Delhi: Suven Life Sciences on Monday said it has secured a product patent in Japan to be used for developing therapeutic agents that are useful in...
Cipla launches Nicotex Nicotine patches Ruby Khatun Khatun22 Aug 2017 10:00 AM ISTMUMBAI: Cipla Health, an arm Cipla with a focus on consumer healthcare products, launched Nicotex Nicotine patches to help a smoker kick the habit in...
Jubilant gets USFDA nod for Drax Exametazime Ruby Khatun Khatun22 Aug 2017 9:45 AM ISTNew Delhi: Drug firm Jubilant Life Sciences on Monday said it has received new drug application approval from the US health regulator for Drax...
New Novartis drug takes aim at tough-to-treat malaria Ruby Khatun Khatun22 Aug 2017 9:30 AM ISTLONDON: Novartis is taking aim at drug-resistant malaria - a growing global problem- by launching clinical trials of the first new antimalarial...
Aurobindo to widen US portfolio, enter new markets in Europe Ruby Khatun Khatun21 Aug 2017 10:30 AM ISTNew Delhi: Aurobindo Pharma has said it would broaden product portfolio in the US while entering new markets in Europe as part of its growth strategy...
Samsung Bioepis teams up with Takeda to develop original biotech drugs Ruby Khatun Khatun21 Aug 2017 10:15 AM ISTSEOUL: Samsung Bioepis Co Ltd said on Monday it will fund and develop multiple original drugs in partnership with Japan's Takeda Pharmaceutical Co...
Amgen and Humana partner for improved health outcomes and efficiency Ruby Khatun Khatun21 Aug 2017 10:00 AM ISTTHOUSAND OAKS, Calif. and LOUISVILLE: Two of the nation's leading health organizations, health and well-being company Humana Inc. and biotechnology...
Bristol-Myers kidney cancer drug fails late-stage trial Ruby Khatun Khatun21 Aug 2017 9:45 AM ISTBristol-Myers Squibb Co said on Tuesday its combination drug to treat previously untreated patients with advanced or metastatic renal cell carcinoma,...
Aurobindo Pharma Q1 net profit down 11 percent at Rs 518 crore Ruby Khatun Khatun20 Aug 2017 10:15 AM ISTNew Delhi: Aurobindo Pharma Ltd reported an 11.38% decline in consolidated net profit at Rs 518.33 crore for the first quarter ended 30 June 2017.The...
